I saw this on Simpily Wall St yesterday (I know not the best place for comprehensive research but they seem to do a good job of bringing data together). Both valuation and earnings/revenue growth is based on data from 7 analysts reports. I'm assuming this doesn't include any revenue from COVID-19 ARDS.
Based on FY 2025 projected earnings of $709m and a market/industry P/E ratio of 19.2-53.7 that gives us a projected 2025 share price of $22.97-$64.23 (based on today's closing price of $5.24 / market cap of $3,106m).
Note that this excludes the potential for COVID-19 ARDS approval and presumably includes risked ratios for earnings of all unapproved products.
I saw this on Simpily Wall St yesterday (I know not the best...
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 97.0¢ | $2.821M | 2.832M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20688 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 35000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |